CRL

Charles River Laboratories International (CRL)

About Charles River Laboratories International (CRL)

Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The RMS segment includes its insourcing solutions business and Charles River accelerator and development lab footprint. The DSA segment offers regulatory-required safety testing of potential new drugs, vaccines, industrial and agricultural chemicals, consumer products, veterinary medicines, and medical devices. The Manufacturing Solutions segment focuses on microbial solutions and biologics solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.

Details

Daily high
$197.64
Daily low
$194.91
Price at open
$196.56
52 Week High
$275.00
52 Week Low
$161.65
Market cap
10.1B
Dividend yield
0.00%
Volume
592,577
Avg. volume
639,849
P/E ratio
23.05

Charles River Laboratories International News

Details

Daily high
$197.64
Daily low
$194.91
Price at open
$196.56
52 Week High
$275.00
52 Week Low
$161.65
Market cap
10.1B
Dividend yield
0.00%
Volume
592,577
Avg. volume
639,849
P/E ratio
23.05